$NKTR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEKTAR THERAPEUTICS. Get notifications about new insider transactions in NEKTAR THERAPEUTICS for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 12 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 18 2017 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Sell | S | 20.76 | 30,000 | 622,800 | 23,450 | 53.5 K to 23.5 K (-56.13 %) |
Jul 18 2017 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Buy | M | 14.26 | 30,000 | 427,800 | 53,450 | 23.5 K to 53.5 K (+127.93 %) |
Jul 13 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | M | 11.04 | 36,691 | 405,069 | 468,672 | |
Jul 13 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | M | 11.04 | 8,389 | 92,615 | 505,363 | |
Jul 13 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 21.09 | 36,691 | 773,813 | 43,572 | 80.3 K to 43.6 K (-45.71 %) |
Jul 13 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Buy | M | 11.04 | 36,691 | 405,069 | 80,263 | 43.6 K to 80.3 K (+84.21 %) |
Jul 13 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 21.04 | 8,389 | 176,505 | 43,572 | 52 K to 43.6 K (-16.14 %) |
Jul 13 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Buy | M | 11.04 | 8,389 | 92,615 | 51,961 | 43.6 K to 52 K (+19.25 %) |
Jun 28 2017 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Option Exercise | M | 8.37 | 15,000 | 125,550 | 0 | |
Jun 28 2017 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Buy | M | 8.37 | 15,000 | 125,550 | 73,000 | 58 K to 73 K (+25.86 %) |
Jun 09 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | M | 6.34 | 150,000 | 951,000 | 0 | |
Jun 09 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 19.24 | 101,700 | 1,956,708 | 227,243 | 328.9 K to 227.2 K (-30.92 %) |
Jun 09 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Buy | M | 6.34 | 150,000 | 951,000 | 328,943 | 178.9 K to 328.9 K (+83.83 %) |
May 18 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 19.55 | 2,651 | 51,827 | 52,986 | 55.6 K to 53 K (-4.76 %) |
May 18 2017 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 19.55 | 8,388 | 163,985 | 160,884 | 169.3 K to 160.9 K (-4.96 %) |
May 18 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 19.55 | 3,146 | 61,504 | 178,943 | 182.1 K to 178.9 K (-1.73 %) |
May 18 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 19.55 | 3,179 | 62,149 | 66,091 | 69.3 K to 66.1 K (-4.59 %) |
May 18 2017 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | S | 19.55 | 2,959 | 57,848 | 60,689 | 63.6 K to 60.7 K (-4.65 %) |
May 18 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 19.55 | 1,450 | 28,348 | 43,572 | 45 K to 43.6 K (-3.22 %) |
May 18 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 19.55 | 1,701 | 33,255 | 32,803 | 34.5 K to 32.8 K (-4.93 %) |
May 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 8.37 | 5,000 | 41,850 | 0 | |
May 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 19.79 | 5,000 | 98,950 | 271,623 | 276.6 K to 271.6 K (-1.81 %) |
May 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 8.37 | 5,000 | 41,850 | 276,623 | 271.6 K to 276.6 K (+1.84 %) |
Apr 19 2017 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 8.37 | 5,000 | 41,850 | 5,000 | |
Apr 19 2017 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 18.72 | 5,000 | 93,600 | 271,623 | 276.6 K to 271.6 K (-1.81 %) |
Apr 19 2017 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 8.37 | 5,000 | 41,850 | 276,623 | 271.6 K to 276.6 K (+1.84 %) |
Apr 11 2017 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Sell | S | 20.05 | 7,000 | 140,350 | 23,450 | 30.5 K to 23.5 K (-22.99 %) |
Apr 07 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | M | 9.53 | 100,000 | 953,000 | 440,000 | |
Apr 07 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 21.70 | 100,000 | 2,170,000 | 34,504 | 134.5 K to 34.5 K (-74.35 %) |
Apr 07 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Buy | M | 9.53 | 100,000 | 953,000 | 134,504 | 34.5 K to 134.5 K (+289.82 %) |
Apr 07 2017 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Option Exercise | M | 13.70 | 180,000 | 2,466,000 | 0 | |
Apr 07 2017 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | S | 21.70 | 180,000 | 3,906,000 | 63,648 | 243.6 K to 63.6 K (-73.88 %) |
Apr 07 2017 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Buy | M | 13.70 | 180,000 | 2,466,000 | 243,648 | 63.6 K to 243.6 K (+282.81 %) |
Apr 07 2017 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | M | 8.37 | 15,000 | 125,550 | 0 | |
Apr 07 2017 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Sell | S | 21.88 | 15,000 | 328,200 | 35,500 | 50.5 K to 35.5 K (-29.70 %) |
Apr 07 2017 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Buy | M | 8.37 | 15,000 | 125,550 | 50,500 | 35.5 K to 50.5 K (+42.25 %) |
Mar 22 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 7.21 | 37,500 | 270,375 | 0 | |
Mar 22 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 11.34 | 75,000 | 850,500 | 0 | |
Mar 22 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 19.69 | 112,500 | 2,215,125 | 55,637 | 168.1 K to 55.6 K (-66.91 %) |
Mar 22 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 7.21 | 37,500 | 270,375 | 168,137 | 130.6 K to 168.1 K (+28.71 %) |
Mar 22 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 11.34 | 75,000 | 850,500 | 130,637 | 55.6 K to 130.6 K (+134.80 %) |
Mar 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 8.37 | 14,000 | 117,180 | 0 | |
Mar 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 8.37 | 14,000 | 117,180 | 98,000 | 84 K to 98 K (+16.67 %) |
Mar 16 2017 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 8.37 | 5,000 | 41,850 | 10,000 | |
Mar 16 2017 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 15.41 | 5,000 | 77,050 | 271,623 | 276.6 K to 271.6 K (-1.81 %) |
Mar 16 2017 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 8.37 | 5,000 | 41,850 | 276,623 | 271.6 K to 276.6 K (+1.84 %) |
Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 9.24 | 25,000 | 231,000 | 0 | |
Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 6.34 | 7,494 | 47,512 | 0 | |
Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 6.34 | 167,506 | 1,061,988 | 7,494 | |
Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 15.21 | 25,000 | 380,250 | 69,270 | 94.3 K to 69.3 K (-26.52 %) |
Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 9.24 | 25,000 | 231,000 | 94,270 | 69.3 K to 94.3 K (+36.09 %) |
Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 15.21 | 7,494 | 113,984 | 69,270 | 76.8 K to 69.3 K (-9.76 %) |
Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 6.34 | 7,494 | 47,512 | 76,764 | 69.3 K to 76.8 K (+10.82 %) |
Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 15.15 | 167,506 | 2,537,716 | 69,270 | 236.8 K to 69.3 K (-70.74 %) |
Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 6.34 | 167,506 | 1,061,988 | 236,776 | 69.3 K to 236.8 K (+241.82 %) |
Feb 23 2017 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | M | 5.14 | 30,000 | 154,200 | 0 | |
Feb 23 2017 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Sell | S | 13.08 | 30,000 | 392,400 | 30,450 | 60.5 K to 30.5 K (-49.63 %) |
Feb 23 2017 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Buy | M | 5.14 | 30,000 | 154,200 | 60,450 | 30.5 K to 60.5 K (+98.52 %) |
Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 13.14 | 1,965 | 25,820 | 55,637 | 57.6 K to 55.6 K (-3.41 %) |
Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 13.14 | 8,636 | 113,477 | 169,272 | 177.9 K to 169.3 K (-4.85 %) |
Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 13.14 | 3,237 | 42,534 | 182,089 | 185.3 K to 182.1 K (-1.75 %) |
Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 13.14 | 2,359 | 30,997 | 69,270 | 71.6 K to 69.3 K (-3.29 %) |
Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | S | 13.14 | 2,195 | 28,842 | 63,648 | 65.8 K to 63.6 K (-3.33 %) |
Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 13.14 | 1,457 | 19,145 | 45,022 | 46.5 K to 45 K (-3.13 %) |
Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 13.14 | 1,261 | 16,570 | 34,504 | 35.8 K to 34.5 K (-3.53 %) |
Feb 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | M | 4.65 | 45,000 | 209,250 | 0 | |
Feb 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Buy | M | 4.65 | 45,000 | 209,250 | 185,326 | 140.3 K to 185.3 K (+32.07 %) |
Feb 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 4.65 | 87,500 | 406,875 | 0 | |
Feb 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 13.04 | 87,500 | 1,141,000 | 177,908 | 265.4 K to 177.9 K (-32.97 %) |
Feb 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 4.65 | 87,500 | 406,875 | 265,408 | 177.9 K to 265.4 K (+49.18 %) |
Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | M | 4.65 | 8,505 | 39,548 | 45,000 | |
Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | M | 4.65 | 66,495 | 309,202 | 53,505 | |
Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 12.48 | 8,505 | 106,142 | 140,326 | 148.8 K to 140.3 K (-5.71 %) |
Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Buy | M | 4.65 | 8,505 | 39,548 | 148,831 | 140.3 K to 148.8 K (+6.06 %) |
Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 12.38 | 66,495 | 823,208 | 140,326 | 206.8 K to 140.3 K (-32.15 %) |
Feb 06 2017 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Buy | M | 4.65 | 66,495 | 309,202 | 206,821 | 140.3 K to 206.8 K (+47.39 %) |
Jan 19 2017 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 4.65 | 87,500 | 406,875 | 87,500 | |
Jan 19 2017 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 12.35 | 87,500 | 1,080,625 | 177,908 | 265.4 K to 177.9 K (-32.97 %) |
Jan 19 2017 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 4.65 | 87,500 | 406,875 | 265,408 | 177.9 K to 265.4 K (+49.18 %) |
Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 12.24 | 37,500 | 459,000 | 37,500 | |
Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Grant | A | 0.00 | 15,000 | 0 | 57,602 | 42.6 K to 57.6 K (+35.21 %) |
Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | A | 12.24 | 137,500 | 1,683,000 | 137,500 | |
Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Grant | A | 0.00 | 55,000 | 0 | 177,908 | 122.9 K to 177.9 K (+44.75 %) |
Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | A | 12.24 | 50,000 | 612,000 | 50,000 | |
Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Grant | A | 0.00 | 20,000 | 0 | 140,326 | 120.3 K to 140.3 K (+16.62 %) |
Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | A | 12.24 | 50,000 | 612,000 | 50,000 | |
Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Grant | A | 0.00 | 20,000 | 0 | 71,629 | 51.6 K to 71.6 K (+38.74 %) |
Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Option Exercise | A | 12.24 | 37,500 | 459,000 | 37,500 | |
Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Grant | A | 0.00 | 15,000 | 0 | 65,843 | 50.8 K to 65.8 K (+29.50 %) |
Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | A | 12.24 | 50,000 | 612,000 | 50,000 | |
Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Grant | A | 0.00 | 20,000 | 0 | 46,479 | 26.5 K to 46.5 K (+75.53 %) |
Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | A | 12.24 | 43,750 | 535,500 | 43,750 | |
Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Grant | A | 0.00 | 17,500 | 0 | 35,765 | 18.3 K to 35.8 K (+95.81 %) |
Dec 09 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 4.65 | 87,500 | 406,875 | 175,000 | |
Dec 09 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 12.24 | 87,500 | 1,071,000 | 122,908 | 210.4 K to 122.9 K (-41.59 %) |
Dec 09 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 4.65 | 87,500 | 406,875 | 210,408 | 122.9 K to 210.4 K (+71.19 %) |
Nov 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 13.96 | 1,986 | 27,725 | 42,102 | 44.1 K to 42.1 K (-4.50 %) |
Nov 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 4.65 | 87,500 | 406,875 | 262,500 | |
Nov 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 13.87 | 87,500 | 1,213,625 | 122,908 | 210.4 K to 122.9 K (-41.59 %) |
Nov 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 4.65 | 87,500 | 406,875 | 210,408 | 122.9 K to 210.4 K (+71.19 %) |
Nov 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 13.96 | 5,958 | 83,174 | 122,908 | 128.9 K to 122.9 K (-4.62 %) |
Nov 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Sell | S | 13.96 | 1,654 | 23,090 | 120,326 | 122 K to 120.3 K (-1.36 %) |
Nov 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 13.96 | 1,654 | 23,090 | 51,129 | 52.8 K to 51.1 K (-3.13 %) |
Nov 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | S | 13.96 | 1,654 | 23,090 | 50,343 | 52 K to 50.3 K (-3.18 %) |
Nov 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 13.96 | 848 | 11,838 | 26,479 | 27.3 K to 26.5 K (-3.10 %) |
Nov 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 13.96 | 670 | 9,353 | 18,265 | 18.9 K to 18.3 K (-3.54 %) |
Oct 25 2016 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | P | 13.50 | 15,000 | 202,500 | 121,333 | 106.3 K to 121.3 K (+14.11 %) |
Oct 06 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 4.65 | 87,500 | 406,875 | 350,000 | |
Oct 06 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 17.06 | 87,500 | 1,492,750 | 128,866 | 216.4 K to 128.9 K (-40.44 %) |
Oct 06 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 4.65 | 87,500 | 406,875 | 216,366 | 128.9 K to 216.4 K (+67.90 %) |
Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 5.14 | 30,000 | 154,200 | 0 | |
Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 8.37 | 1,000 | 8,370 | 14,000 | |
Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 5.15 | 15,000 | 77,250 | 0 | |
Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 5.14 | 30,000 | 154,200 | 84,000 | 54 K to 84 K (+55.56 %) |
Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 8.37 | 1,000 | 8,370 | 54,000 | 53 K to 54 K (+1.89 %) |
Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 5.15 | 15,000 | 77,250 | 53,000 | 38 K to 53 K (+39.47 %) |
Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Option Exercise | A | 19.15 | 20,000 | 383,000 | 20,000 | |
Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Grant | A | 0.00 | 8,000 | 0 | 34,250 | 26.3 K to 34.3 K (+30.48 %) |
Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 19.15 | 20,000 | 383,000 | 20,000 | |
Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Grant | A | 0.00 | 8,000 | 0 | 38,000 | 30 K to 38 K (+26.67 %) |
Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | A | 19.15 | 20,000 | 383,000 | 20,000 | |
Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Grant | A | 0.00 | 8,000 | 0 | 30,450 | 22.5 K to 30.5 K (+35.63 %) |
Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | A | 19.15 | 20,000 | 383,000 | 20,000 | |
Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Grant | A | 0.00 | 8,000 | 0 | 35,500 | 27.5 K to 35.5 K (+29.09 %) |
Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Option Exercise | A | 19.15 | 20,000 | 383,000 | 20,000 | |
Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Grant | A | 0.00 | 8,000 | 0 | 58,000 | 50 K to 58 K (+16.00 %) |
Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 19.15 | 20,000 | 383,000 | 20,000 | |
Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Grant | A | 0.00 | 8,000 | 0 | 106,333 | 98.3 K to 106.3 K (+8.14 %) |
Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | A | 19.15 | 20,000 | 383,000 | 20,000 | |
Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Grant | A | 0.00 | 8,000 | 0 | 271,623 | 263.6 K to 271.6 K (+3.03 %) |
Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Buy | M | 0.00 | 15,000 | 0 | 26,250 | 11.3 K to 26.3 K (+133.33 %) |
Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 0.00 | 15,000 | 0 | 30,000 | 15 K to 30 K (+100.00 %) |
Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Buy | M | 0.00 | 15,000 | 0 | 22,450 | 7.5 K to 22.5 K (+201.34 %) |
Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Sell | S | 19.06 | 9,000 | 171,540 | 7,450 | 16.5 K to 7.5 K (-54.71 %) |
Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Sell | S | 19.13 | 7,500 | 143,475 | 27,500 | 35 K to 27.5 K (-21.43 %) |
Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Buy | M | 0.00 | 15,000 | 0 | 35,000 | 20 K to 35 K (+75.00 %) |
Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Buy | M | 0.00 | 15,000 | 0 | 50,000 | 35 K to 50 K (+42.86 %) |
Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 0.00 | 15,000 | 0 | 98,333 | 83.3 K to 98.3 K (+18.00 %) |
Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 0.00 | 15,000 | 0 | 263,623 | 248.6 K to 263.6 K (+6.03 %) |
Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 19.21 | 12,000 | 230,520 | 248,623 | 260.6 K to 248.6 K (-4.60 %) |
Sep 02 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 4.65 | 87,500 | 406,875 | 437,500 | |
Sep 02 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 17.83 | 87,500 | 1,560,125 | 128,886 | 216.4 K to 128.9 K (-40.44 %) |
Sep 02 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 4.65 | 87,500 | 406,875 | 216,366 | 128.9 K to 216.4 K (+67.90 %) |